If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
I doubt very much anything will happen with the Taiwan Gov. I suspect they are about to be invaded by China...
However, in the current climate of high inflation I also suspect we will be locked down again to mute demand quickly and shut down rampant inflation. Covid is a weapon, as is the dollar and oil...
This is my play here and I will hold for years to watch it play out....
GLA
Hi All,
Glad abdx have been cleared, but i wouldn't celebrate too quickly... abdx need to get confirmed contracts in & sticky revenue. If they don't its all just BS.
We're about to go into an economic depression & covid is now low on all Governments agenda.
Let's hope they secure, no BS pretend / fake deals, like deepverge, vatic, etc., but some really strong contracts & earnings.
IF they do, I don't see why this won't fly... I mean really fly. If they don't, well I guess we'll all have to write down our investment into this.
I'm deeply underwater here, but I remain hopeful
GLA
Only one thing maters... new sticky annual revenue; If they are able to make their contract manufacturing plan work they need confirmed orders... That's it.
The management are paying themselves plenty, which is not good for us shareholders in view of their performance thus far.
They talk a big game but no orders.
Show us the orders & revenue & new investment will come.
In a warehouse so vast it once housed torpedoes during the second world war, Randox marshalled its troops of testers to detect Covid-19 across the UK. Like wars, pandemics spur innovation and the Northern Irish diagnostics company adapted quickly. Within weeks of the outbreak, it created a test, rapidly scaled up in a time of shortage by making its own chemicals and machines, and developed robots to get tests done faster.
Along the way, Randox became one of the so-called winners of the pandemic, making a fortune and increasing its brand recognition. While its work was key in the country’s fight against Covid, it also came under scrutiny for its links to the UK government as concerns were raised about the procurement process.
Now the need for testing is easing, Randox intends to use the hundreds of millions of pounds it made in the pandemic for a new purpose: giving people control over their own health tests.
Peter Fitzgerald, a scientist, founded the company 40 years ago, leading Randox as it outgrew its original office in a former chicken shed. The company expanded to distribute its products to test for everything from diabetes to infectious diseases in more than 145 countries, before investing in novel diagnostics.
Unhappy with the UK’s approach to testing, Fitzgerald long dreamt of transforming healthcare by screening asymptomatic people to identify latent medical problems. Testing is essential, he says, to really understand what’s going on inside the body.
While the second world war proved the power of the public sector, making the case for a national health service, the pandemic pushed the government towards private providers for testing and extra hospital beds. As the public health service struggles to clear a record backlog, more patients are opting for private care — and Randox hopes more people will want help to spot early signs of illness.
Randox always had a plan to expand its health clinics. But it had far less money to fund its ambitions, making a loss of £12.5mn in the 18 months ending in June 2020, and a profit of £167,000 in the period before that. After winning 22 government testing contracts totalling £469mn, plus revenues from its private Covid testing business, Randox generated a pre-tax profit of £275mn in the year to June 2021.
Abdx need to attract institutional investors, fast or get back in bed with the government ??... surescreen profits gone from £1m to £67m! An incredible success story. Abdx need to get some concrete contracts in & decent £££revenue in, fast. They don't want to be missing the winter covid rally this 2022 or were in trouble.
I have a large position in this stock & I'm underwater like many people...
There's so much potential but the company seems to be run badly.
I'm really disappointed with the communication from Abingdon & the PR from Walbrook & Paul McManus, specifically; They're running a mickymouse operation & it needs overhauling with a decent PR firm.
They need to build a proper pipeline & get some decent orders in ASAP.
Investor confidence is nonexistent.
'Winter is coming' in more ways than one & Abdx need to sort it out in the next few months or this could be a flop.
Really really disappointing.
It is probably not great news on balance I would say (relative to what I was expecting / hoping for, anyway), however I am certainly happy to be wrong.
they may be getting paid £9m, but if you read ABDX cannot withdraw any of the monies due to be paid (no evidence of payment yet) without consent from DHSC and DHSC have a £ claim on ABDX bank balance, probably to the tune of £9m! Effectively this is like a form of impending nationalisation, if things go pair shaped. This is exactly what the Government want a company to supply them where they have a charge / claim and possibility to nationalise.
There is no point in having money owed to them if they can't use it and now ABDX are even deeper with a crooked Government.
There is only one potential silver lining that I can see atm: It is possible that the Government plan to use ABDX for further orders during subsequent pandemics. However, my research suggests that they use another company for that already, Surescreen (?) so I don't know if this is viable? Can anyone comment on this?
That said the share price is rising as I write this, so maybe I'm missing something or there are further pieces of the puzzle to come?
Fingers crossed & good luck to all.
Hi All,
Everything here points towards a potential big rise, certainly in the longer term, I.e. 1 to 5 years.
My one concern atm is investor sentiment.
Abdx management really must work hard now at rebuilding investor confidence to flush out the day traders & short sellers or price rises/ rerates simply aren't sustainable.
Stating the obvious, they need long term buy & hold investors.
I get why they IPO'd as they did & the 25p placing; I actually think they did very well with it & saved their business. They are demonstrating that they're building a good pipeline too, but now they have to show the market that they are here to stay & that they are straight shooters looking to provide long term value for their investors.
Let's hope got the memo.
Fyi, Pfizer have just announced their view that covid is going to be back at Xmas. People seem to have forgotten....
GLA
https://www.tradingview.com/symbols/LSE-ABDX/
Shortsellers who have sold call options have unlimited loss liability.
GLA
It keeps retesting but eventually once the bottle neck is cleared, one way or another, i think it'll bounce hard like a synairgen from 23 to 248, which is a c. 11x. I bought this because it is so under priced. Once news hits the market, I believe it'll do us proud, but patience it required.
And it begins ....
Those who are buying at these levels will probably do well. If we get paid by DHSC, it's a no brainer.
I suspect that holding through past Xmas 2022 and longer term is a good bet. As previously, this is a growth sector. Can you imagine if the NHS start to incorporate home testing diagnostics through to prescription & delivery to try and clear the back log of patients they have ... OMG
Patience grasshoppers.
GLA
https://www.lse.co.uk/rns/ABDX/strategic-collaboration-with-bimelix-ab-066zygnw4gf076w.html
https://www.yorkshirepost.co.uk/business/york-based-abingdon-health-signs-partnership-agreement-which-could-help-control-spread-of-lyme-disease-3690502